Xiaoxia Jiang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer.

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer.

Journal: Frontiers in oncology
Published: September 26, 2019

VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer.

VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer.

Journal: Translational oncology
Published: June 24, 2019

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer.

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer.

Journal: Molecular medicine reports
Published: January 30, 2019

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer.

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer.

Journal: Cancer management and research
Published: December 28, 2018

GPRC5A: An Emerging Biomarker in Human Cancer.

GPRC5A: An Emerging Biomarker in Human Cancer.

Journal: BioMed research international
Published: June 05, 2018

BP‑1‑102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways.

BP‑1‑102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways.

Journal: Molecular medicine reports
Published: May 19, 2018

Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis.

Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis.

Journal: Molecular medicine reports
Published: March 16, 2017

FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway.

FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway.

Journal: Journal of Cancer
Published: January 20, 2017

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.

Journal: OncoTargets and therapy
Published: December 14, 2016

Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis.

Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis.

Journal: OncoTargets and therapy
Published: May 14, 2016

Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.

Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.

Journal: BMC cancer
Published: October 15, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026